| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Sep―09 |
Clinical and laboratory characteristics of the novel coronavirus infection COVID-19 in patients with concomitant oncological pathology |
l.D. Kanner, Zh.B. Ponezheva, D.V. Usenko |
| 2 |
[GO] |
2025―Dec―29 |
Clinical and laboratory patterns of COVID-19 in first-time and repeatedly hospitalized patients with bacterial co-infection |
Zh.B. Ponezheva, L.K. Alimova, E.A. Burdakova, I.V. Mannanova, N.S. Martynova, I.D. Kanner, D.V. Usenko |
| 3 |
[GO] |
2025―Dec―29 |
Predictors of mortality in patients with COVID-19 |
A.E. Evdokimova, Kh.S. Khaertynov, V.A. Anokhin, I.S. Raginov, A.M. Sabitova |
| 4 |
[GO] |
2025―Oct―01 |
SARS-CoV-2 infection in patients with cancer: analyzing the pandemic outcomes |
I.D. Kanner, D.V. Usenko |
| 5 |
[GO] |
2025―Jul―24 |
Systemic inflammation and intestinal microbiocenosis in patients with COVID-19: a role of macrophage inflammatory proteins in the disease pathogenesis |
N.S. Martynova, Zh.B. Ponezheva, N.G. Kulikova, L.A. Bityumina, E.N. Lazareva, D.V. Usenko, E.T. Vdovina |
| 6 |
[GO] |
2025―Jan―10 |
Risk factors for the adverse course of COVID-19 in patients with tuberculosis |
N.D. Urushadze, N.Yu. Pshenichnaya, L.E. Parolina, V.S. Burykhin, S.N. Skornyakov, I.A. Vasilyeva |
| 7 |
[GO] |
2024―Apr―12 |
Outpatient lipid-lowering therapy in patients at very high cardiovascular risk during the COVID-19 pandemic |
V.A. Sergeeva, T.E. Lipatova |
| 8 |
[GO] |
2023―Dec―21 |
Antiviral therapy for COVID-19 |
Yu.A. Larchenko, O.Yu. Agapova, G.G. Mar'in, O.E. Vakhrushkina, M.V. Kukharenok, S.Yu. Nistor, T.F. Guseva, E.A. Medvedeva, K.A. Zykov |
| 9 |
[GO] |
2023―Dec―21 |
Effect of the COVID-19 pandemic on the psychological well-being of students and teachers of medical higher education institutions |
G.G. Mar'in, E.A. Medvedeva, N.I. Usol'ceva, G.A. Gorbeshko, O.A. Svitich, K.A. Zykov, A.A. Ploskireva, D.A. Nazarov, M.A. Kinkul'kina, K.G. Romanova, M.V. Chernogorova |
| 10 |
[GO] |
2023―Dec―21 |
SARS-CоV-2: what allowed the virus to cause a long-term pandemic? |
D.V. Pechkurov, A.A. Romanova, O.A. Savvateev, A.A. Tyazheva, A.V. Gorelov |
| 11 |
[GO] |
2023―Jun―30 |
Risk factors of COVID-19: immunological aspects |
T.V. Glazanova, E.R. Shilova, I.E. Pavlova |
| 12 |
[GO] |
2023―Jun―30 |
Problems of mental disorder in the context of the COVID-19 pandemic |
P.I. Litvinenko, O.V. Tsygankova, L.D. Khidirova, A.A. Starichkova |
| 13 |
[GO] |
2023―Jun―19 |
Coronavirus disease and dyslipidemia - is there an association? |
V.A. Akhmedov |
| 14 |
[GO] |
2023―May―31 |
Takayasu's arteritis after coronavirus disease in young woman: case report |
I.G. Gordeev, V.I. Vechorko, S.M. Otarova, V.P. Rauzheva, A.R. Yunyaev |
| 15 |
[GO] |
2022―Dec―26 |
Evolution of the clinical and pathogenetic characteristics of the coronavirus disease COVID-19 |
A.V. Gorelov, A.A. Ploskireva, A.D. Muzyka |
| 16 |
[GO] |
2022―Dec―26 |
Experience with the use of Azoximer bromide for the prevention of acute respiratory infections and COVID-19 in adults from the group with a higher risk of contracting the infection ("red zone" healthcare workers): meta-analysis of controlled clinical trials |
Kh.G. Omarova, A.A. Ploskireva, I.A. Agarkova, A.V. Gorelov |
| 17 |
[GO] |
2022―Dec―26 |
Clinical characteristics of the novel coronavirus infection in HIV-positive patient with underlying chronic hepatitis C |
I.A. Matyazh, E.V. Ivakhnenko, A.V. Grokhotova |
| 18 |
[GO] |
2022―Nov―16 |
Pulmonary surfactant in the complex treatment of severe pneumonia associated with COVID-19. Efficacy markers |
E.V. Volchkova, Yu.Sh. Alexandrovich, O.N. Titova, N.A. Kuzubova, V.A. Volchkov, D.P. Piskunov, M.N. Bakholdina, F.I. Bitakova |
| 19 |
[GO] |
2022―Nov―16 |
Long-term effects of COVID-19 in patients according to the functional lung imaging in radiation therapy |
V.P. Zolotnitskaya, A.A. Speranskaya, N.A. Kuzubova, O.N. Titova, O.V. Amosova |
| 20 |
[GO] |
2022―Nov―16 |
Postcovid syndrome: risk factors, pathogenesis, diagnosis and treatment of patients with respiratory damage after COVID-19 (overview) |
T.N. Bilichenko |
| 21 |
[GO] |
2022―Apr―11 |
COVID-19-associated myocarditis: clinical pattern and medical treatment |
V.A. Sergeeva, T.E. Lipatova |
| 22 |
[GO] |
2021―Dec―21 |
Case series of secondary thrombotic microangiopathy in children with multisystem inflammatory syndrome associated with COVID-19 |
D.V. Novikov, T.S. Sabinina, T.V. Shalbarova, O.L. Chugunova, E.V. Melekhina |
| 23 |
[GO] |
2021―Dec―21 |
Preliminary results of an adaptive randomized open-label controlled study on the efficacy and safety of enisamium iodide for outpatient treatment of the COVID-19 infection |
N.Yu. Pshenichnaya, K.V. Zhdanov |
| 24 |
[GO] |
2021―Dec―21 |
Acute respiratory infections and flu during the COVID-19 pandemic. What to expect in 2021-2022? |
D.V. Usenko, N.Kh. Tkhakushinova, T.T. Shaturina, L.A. Ledenko, O.V. Bevzenko |
| 25 |
[GO] |
2021―Dec―21 |
Cetylpyridinium chloride as a part of a combined medication for adults and children during the COVID-19 pandemic: established and perspective use |
E.V. Melekhina, A.D. Muzyka, Zh.B. Ponezheva, A.V. A.V. Gorelov |
| 26 |
[GO] |
2021―Dec―21 |
COVID-19 vaccination of pregnant women: state-of-the-art |
A.A. Girina, A.L. Zaplatnikov, V.I. Svintsitskaya, S.D. Izhogina |
| 27 |
[GO] |
2021―Nov―19 |
Asthenic and cognitive disorders after the COVID-19 infection |
P.R. Kamchatnov, E.Yu. Solov’eva, D.R. Khasanova, V.V. Fateeva |
| 28 |
[GO] |
2021―Nov―11 |
Effects of SARS-CoV-2 on the endocrine system |
N.A. Petunina, A.S. Shkoda, M.E. Telnova, E.V. Goncharova, I.A. Kuzina, Y.А. El-Taravi, N.S. Martirosian |
| 29 |
[GO] |
2021―Oct―19 |
Pulmonary fibrosis associated with COVID-19 |
N.A. Kuzubova, O.N. Titova, E.S. Lebedeva, E.V. Volchkova |
| 30 |
[GO] |
2021―Oct―19 |
Therapeutic possibilities of using an expectorant mucolytic agent with antioxidant properties in COVID-19 infection |
G.L. Ignatova, V.N. Antonov, E.V. Sheklanova, M.A. Korotkaya, M.V. Domracheva, S.O. Zotov |
| 31 |
[GO] |
2021―Oct―19 |
Possibilities of immunocorrection in COVID-19 therapy of patients on an outpatient basis |
L.R. Mukhamadieva, G.A. Mavzyutova, G.Kh. Mirsayeva, G.M. Khasanova, G.A. Galieva, G.M. Abdrakhmanova, A.A. Safina |
| 32 |
[GO] |
2021―Oct―12 |
Diarrhea syndrome: new accents of patient curation during COVID-19 pandemic |
O.V. Gaus, M.A. Livzan |
| 33 |
[GO] |
2021―Oct―12 |
Risk factors, immunological mechanisms and biological markers of severe COVID-19 course (study overview) |
T.N. Bilichenko |
| 34 |
[GO] |
2021―Oct―12 |
Characteristics of complex therapy of immuno-inflammatory rheumatic diseases in COVID-19 pandemic conditions |
R.R. Samigullina, V.I. Mazurov, E.A. Trofimov |
| 35 |
[GO] |
2021―Oct―12 |
Electrolyte deficiency after the novel coronavirus infection and post-COVID asthenia |
E.Yu. Ebzeeva, O.D. Ostroumova, I.F. Krotkova, E.V. Mironova, R.R. Romanovskiy |
| 36 |
[GO] |
2021―May―13 |
Patterns of the rheumatic disease course in the setting of a new coronavirus infection |
V.V. Vakhlevskiy, V.V. Tyrenko, I.S. Svintsitskaya, E.V. Kryukov |
| 37 |
[GO] |
2020―Dec―23 |
Seasonal flu shot and the COVID-19 pandemic: don’t miss the last chance |
A.L. Zaplatnikov, A.A. Girina, E.I. Burtseva, V.I. Svintsitskaya |
| 38 |
[GO] |
2020―Nov―30 |
Prospects for the use of micronutrients in the treatment of coronavirus infection in patients with comorbid pathology |
O.A. Gromova, I.Yu. Torshin, A.M. Lila, A.V. Naumov, S.I. Malyavskaya |
| 39 |
[GO] |
2020―Oct―19 |
Acute respiratory infections in outpatient care in the era of the COVID-19 pandemic: the role and position of antibacterial therapy |
R.F. Khamitov |
| 40 |
[GO] |
2020―Oct―19 |
Pathogenetically-oriented therapy for novel coronavirus infection |
L.R. Mukhamadieva, G.A. Mavzyutova, E.B. Tyurina, O.Z. Kuzovkina |
